Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance-Reference-Cited by-同舟云学术

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance

Published:2016-06-05 Issue:26 Volume:7 Page:39293-39301
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Módos Orsolya¹,Reis Henning²,Niedworok Christian³,Rübben Herbert³,Szendröi Attila¹,Szász Marcell A.⁴,Tímár József⁴,Baghy Kornélia⁵,Kovalszky Ilona⁵,Golabek Tomasz⁶,Chlosta Piotr⁶,Okon Krzysztof⁷,Peyronnet Benoit⁸,Mathieu Romain⁸,Shariat Shahrokh F.⁹,Hollósi Péter⁵¹⁰,Nyirády Péter¹,Szarvas Tibor¹³

Affiliation:

1. Department of Urology, Semmelweis University, Budapest, Hungary

2. Institute of Pathology, University of Duisburg-Essen, Essen, Germany

3. Department of Urology, University of Duisburg-Essen, Essen, Germany

4. 2nd Department of Pathology, Semmelweis University, Budapest, Hungary

5. 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary

6. Department of Urology, Jagiellonian University, Krakow, Poland

7. Department of Pathomorphology, Jagiellonian University, Krakow, Poland

8. Department of Urology, Rennes University Hospital, Rennes, France

9. Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria

10. Tumor Progression Research Group, Hungarian Academy of Sciences, Budapest, Hungary

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urachal Carcinoma: Insights From a National Database;Clinical Genitourinary Cancer;2024-12

2. Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study;JCO Precision Oncology;2024-08

3. Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinoma;International Journal of Surgery Case Reports;2024-04

4. Urachal Adenocarcinoma: A Rare Primary Cancer Managed With FOLFOX Chemotherapy;Cureus;2023-08-21

5. Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma;Frontiers in Pharmacology;2023-05-30